Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update
GALE-401 expected to initiate a Phase 3 clinical trial in Q2, 2017 Top-Line results from NeuVax™ (nelipepimut-S) PRESENT Clinical Trial Webcast and conference call today at 2:00 p.m. P.T. / 5:00 p.m. E.T. SAN RAMON, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) …